GR
Insider selling
Gilead Raday sold $1K of RDHL stock
Gilead Raday, Chief Operating Officer of RedHill Biopharma Ltd. (RDHL), sold 14,310,000 shares of RDHL stock worth $1K, per an SEC Form 4 filed Oct 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 1, 2026, 5 days before it was made public.
RDHL has moved -19.2% since the trade date, from $0.48 to $0.39 (Oct 30, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 5 days
- Price since
- -19.2%
- Role
- Chief Operating Officer
- Source
- SEC Form 4
More RDHL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.